衰老和性对角质神经密度和功能的影响
Giuseppe Suanno1,2, Philippe Fonteyne1, Massimo De Micheli3
1Vita-Salute San Raffaele University, Milan, Italy.
Investigative ophthalmology & visual science
|March 3, 2026
概括
衰老显著影响角膜神经,在小鼠中减少密度和功能. 与雄性相比,雌性小鼠表现出对神经退行和神经炎症的保护.
科学领域:
- 眼科医生 眼科 眼科
- 神经科学是一个神经科学.
- 老年学是指老年学的学科.
背景情况:
- 角膜神经的结构和功能对于眼睛的健康至关重要.
- 衰老与神经退行和感官知觉改变有关.
- 在生物系统中,人们越来越多地认识到衰老过程中的性别差异.
研究的目的:
- 研究衰老和性别对小鼠角膜神经形态和功能的影响.
- 识别导致角膜神经衰老的细胞和分子机制.
- 为了比较雄性和雌性小鼠之间的角膜神经与年龄相关的变化.
主要方法:
- 使用年轻和老的雄性和雌性C57BL/6N小鼠.
- 通过擦拭眼睛和科切-邦内测试来评估角膜神经功能.
- 使用β3布林染色量化角膜神经密度.
- 通过免疫光学和RT-PCR分析了三角骨中的神经元和神经炎症标志物.
主要成果:
- 随着年龄的增长,角膜神经密度和感觉反应显著降低.
- 雄性小鼠表现出机械灵敏度下降,与雌性不同.
- 雌性小鼠表现出较轻的神经纤维退化,并保留了M2巨细胞数量.
- 衰老增加了三腺中的白细胞吸收,女性的效果较轻微.
- 雌性小鼠在三关节中表现出神经保护标记物的更高表达.
结论:
- 衰老诱导感官角膜神经病变和神经炎症.
- 雌性小鼠表现出对与年龄相关的角膜神经退化有保护作用.
- 神经保护和炎症的性别差异影响角膜神经衰老.
相关概念视频
The Effect of Aging on Tissues
3.6K
Several body functions deteriorate with age. The external signs of aging are easily identifiable. For example, the skin becomes dry, less elastic, and thins out, forming wrinkles. The skin of the face begins to appear looser due to a decrease in the levels of elastic and collagen fibers in the connective tissue. Additionally, melanin production in the hair follicle decreases with age, resulting in gray hair. Moreover, the senses of sight and hearing decline, so glasses and hearing aids may...
3.6K
Bone Disorders
8.0K
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
8.0K
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
857
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
857
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
378
Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are...
378
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
352
In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
352
Pharmacodynamics in Geriatric Patients: Effects of Age
366
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
366


